imatinib mesylate has been researched along with Deficiency of GP 2b 3a Complex in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chaubey, R; Chauhan, R; Chhikara, S; Dange, P; Deka, R; Mahapatra, M; Ragesh R Nair, R; Saxena, R; Sazawal, S; Singh, K; Veetil, KK | 1 |
1 other study(ies) available for imatinib mesylate and Deficiency of GP 2b 3a Complex
| Article | Year |
|---|---|
Reversal of Glanzmann thrombasthenia platelet phenotype after imatinib treatment in a pediatric chronic myeloid leukemia patient.
Topics: Antineoplastic Agents; Child; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Thrombasthenia | 2018 |